2003
DOI: 10.1016/s0735-1097(03)82532-9
|View full text |Cite
|
Sign up to set email alerts
|

The metabolic syndrome, diabetes, and subclinical atherosclerosis assessed by coronary calcium

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
31
1

Year Published

2004
2004
2011
2011

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 25 publications
(33 citation statements)
references
References 0 publications
1
31
1
Order By: Relevance
“…[3][4][5] Furthermore, the presence and extent of coronary calcification is prognostically important and adds incremental prognostic information beyond that of traditional cardiovascular risk factors. [6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24] Therefore, in patients suspected of having CAD, a combined evaluation of both stress MPI and CACS could incrementally add to their correct classification [25][26][27][28][29][30] and could significantly change clinical management.…”
Section: Introductionmentioning
confidence: 99%
“…[3][4][5] Furthermore, the presence and extent of coronary calcification is prognostically important and adds incremental prognostic information beyond that of traditional cardiovascular risk factors. [6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24] Therefore, in patients suspected of having CAD, a combined evaluation of both stress MPI and CACS could incrementally add to their correct classification [25][26][27][28][29][30] and could significantly change clinical management.…”
Section: Introductionmentioning
confidence: 99%
“…The high coronary calcium score did not significantly impair the overall diagnostic accuracy of MSCT for detecting significant coronary stenoses. This finding may be of particular importance for the diabetic patient population, since it has been observed that the prevalence and the extent of coronary calcifications in diabetic patients is higher than in the nondiabetic population [16]. Moreover, advanced atherosclerotic plaque burden may even be present without evident clinical symptoms.…”
mentioning
confidence: 89%
“…13,14 This type of tiered testing has also been advocated for patients with the metabolic syndrome and for those with a family history of premature CHD. 15,16 Another approach is that imaging should not be performed because all of the high FRS patients should be treated to secondary prevention goals and that imaging will not alter this management course. There are no comparative trials on this subject but concern over the added contribution of ischemia to patient management in patients without cardiac symptoms remains an important consideration for high-risk patient subsets.…”
Section: Potential Use Of Rmpi Based On Risk Assessmentmentioning
confidence: 99%